What’s new with GLP-1 medications in 2026? In this episode of Funny Medicine Podcast, we break down the latest updates on Ozempic, Wegovy, Zepbound, Mounjaro, semaglutide, tirzepatide, and next-generation GLP-1 drugs.

We first covered this topic when GLP-1s were just starting to dominate the conversation. Now, a few years later, we’re looking at what happened next: the benefits, the concerns, the research updates, and why these medications have become one of the biggest health topics in medicine, wellness, and pop culture. In this episode, we talk about:

• what GLP-1 drugs actually do in the body

• semaglutide and tirzepatide updates

• Ozempic, Wegovy, Mounjaro, and Zepbound differences

• weight loss, food noise, metabolism, and appetite changes

• GLP-1s and sleep apnea

• GLP-1s and addiction, reward pathways, and brain effects

• muscle loss, protein intake, and strength training

• side effects, safety concerns, and who should avoid them

• cancer questions, pancreatitis concerns, vision changes, and ongoing research

• oral GLP-1 pills and what may be coming next

We also get into the real-world conversation around these medications: why some people see them as life-changing, why others are skeptical, and what science actually says right now. If you’ve been curious about Ozempic, Wegovy, Zepbound, Mounjaro, GLP-1 side effects, GLP-1 benefits, GLP-1 risks, or the latest weight loss drug updates, this episode is for you.

THIS PODCAST IS FOR ENTERTAINMENT PURPOSES ONLY AND DOES NOT SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE.

New episodes every other Tuesday.

📱 Follow Funny Medicine Podcast on all social platforms for bonus content, behind-the-scenes moments, and community discussions.

Support the show

• Drop a comment with your questions or stories

🔔 Subscribe: https://bit.ly/FunnyMedicineSubscribe

Instagram & Threads: @funnymedicinepodcast

Twitter/X: @FunnyMedPod

TikTok: @funnymedicinepodcast

References listed in video version of this episode on Youtube.